ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728

ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728

Related Keywords

Australia ,Sydney ,New South Wales ,Arthur Roach ,Rapid Eye Movement Sleep Behaviour Disorder ,Cohort Review Committee ,University Of Oxford ,Boehringer Ingelheim ,University Of Sydney ,United Kingdom ,